U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07212686) titled 'Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension' on June 16.
Brief Summary: The goal of this clinical trial is to determine the safety and efficacy of Angiotensin-II in the treatment of pediatric patients in fluid refractory vasodilatory shock. The main questions it aims to answer are:
* To evaluate the change in blood pressure or reduction of vasoactive requirements (norepinephrine equivalent dosing) after initiating Angiotensin II
* To establish the safety and tolerability of Angiotensin-II in pediatric patients Participants will receive Angiotensin-II in addition to standard of care therapy fo...